Fact checked by Nick Blackmer The Food and Drug Administration (FDA) has expanded its approval of a ketamine nasal spray, ...

Padagis®, a leading generic manufacturer, announced today it is lowering the price of its over-the-counter (OTC) 4 mg ...

The FDA has accepted for review the NDA for bumetanide nasal spray for edema associated with CHF, as well as hepatic and renal disease.

A nasal spray that contains esketamine — a potent derivative of ketamine — can now be taken on its own to treat adults with ...

The US Food and Drug Administration (FDA) has approved the use of esketamine nasal spray as a standalone treatment for adults with major depressive disorder (MDD) who have not responded adequately ...

The FDA has approved the use of Spravato, an antidepressant nasal spray, as a standalone treatment for depression in the U.S. Sue Varma discusses why she supports the use of the drug and how it may ...

Ketamine has been used as an anesthetic before surgeries for decades, but it can also be an option for those struggling with ...

Mumbai: Global pharma major Lupin Limited has announced that it has received tentative approval from the United States Food ...

People in Phoenix suffering from severe depression now have a Ketamine-derived nasal spray available for treatment.

A major trial in frontotemporal dementia patients has found that oxytocin can help improve symptoms of apathy. A new study ...

The results, which come on the heels of the FDA’s approval of J&J’s esketamine nasal spray Spravato as a monotherapy for ...

Public health experts have concerns about the opioid reversal agent Opvee. But the company that makes it, Indivior, has found ...